Barclays PLC Sc Pharmaceuticals Inc. Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Barclays PLC holds 66,199 shares of SCPH stock, worth $375,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,199

Previous 66,199 -0.0%

Holding current value

$375,348

Previous $252,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$2.02 - $4.27 $39,563 - $83,632	19,586 Added 42.02%	66,199 $252,000
Q1 2025 May 15, 2025	SELL	$2.63 - $3.68 $49,307 - $68,992	-18,748 Reduced 28.68%	46,613 $122,000
Q4 2024 Feb 13, 2025	BUY	$3.14 - $4.53 $77,611 - $111,968	24,717 Added 60.81%	65,361 $232,000
Q3 2024 Nov 15, 2024	BUY	$4.12 - $5.51 $127,316 - $170,270	30,902 Added 317.2%	40,644 $186,000
Q2 2024 Aug 14, 2024	SELL	$3.51 - $5.21 $37,072 - $55,028	-10,562 Reduced 52.02%	9,742 $43,000
Q1 2024 May 15, 2024	SELL	$4.86 - $6.39 $94,191 - $123,844	-19,381 Reduced 48.84%	20,304 $102,000
Q4 2023 Feb 15, 2024	BUY	$4.7 - $6.63 $162,446 - $229,152	34,563 Added 674.8%	39,685 $249,000
Q3 2023 Nov 07, 2023	SELL	$7.0 - $9.82 $4,438 - $6,225	-634 Reduced 11.01%	5,122 $37,000
Q2 2023 Aug 03, 2023	SELL	$8.94 - $11.74 $605,166 - $794,704	-67,692 Reduced 92.16%	5,756 $58,000
Q1 2023 May 04, 2023	BUY	$5.59 - $9.47 $410,574 - $695,552	73,448 New	73,448 $666,000
Q4 2021 Feb 14, 2022	SELL	$3.88 - $6.9 $3,158 - $5,616	-814 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$4.93 - $7.15 $216 - $314	44 Added 5.71%	814 $5,000
Q2 2021 Aug 13, 2021	SELL	$5.19 - $7.38 $26,360 - $37,483	-5,079 Reduced 86.84%	770 $5,000
Q1 2021 May 13, 2021	BUY	$5.65 - $7.66 $20,289 - $27,507	3,591 Added 159.03%	5,849 $39,000
Q4 2020 Feb 11, 2021	SELL	$5.17 - $9.41 $4,472 - $8,139	-865 Reduced 27.7%	2,258 $12,000
Q3 2020 Nov 12, 2020	BUY	$7.12 - $8.86 $982 - $1,222	138 Added 4.62%	3,123 $24,000
Q2 2020 Aug 12, 2020	BUY	$7.01 - $10.96 $20,924 - $32,715	2,985 New	2,985 $22,000
Q4 2019 Feb 10, 2020	SELL	$4.1 - $6.21 $582 - $881	-142 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.24 - $7.35 $456 - $1,036	141 Added 14100.0%	142 $1,000
Q2 2019 Aug 14, 2019	SELL	$2.48 - $3.76 $5,173 - $7,843	-2,086 Reduced 99.95%	1 $0
Q1 2019 May 15, 2019	BUY	$2.84 - $4.18 $5,367 - $7,900	1,890 Added 959.39%	2,087 $6,000
Q4 2018 Feb 14, 2019	SELL	$3.76 - $5.61 $9,478 - $14,142	-2,521 Reduced 92.75%	197 $1,000
Q3 2018 Nov 14, 2018	BUY	$4.22 - $6.03 $8,440 - $12,060	2,000 Added 278.55%	2,718 $16,000
Q2 2018 Aug 14, 2018	SELL	$5.53 - $15.4 $4,462 - $12,427	-807 Reduced 52.92%	718 $3,000
Q1 2018 May 15, 2018	BUY	$11.62 - $17.32 $17,720 - $26,413	1,525 New	1,525 $19,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

36.4M

Call Options Held

757K

Put Options Held

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $155M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account